Some countries do their utmost to preserve chaos in Middle East — PutinRussian Politics & Diplomacy October 19, 17:42
Putin: Previous recipes for tackling conflicts do not work, new ones not yet foundRussian Politics & Diplomacy October 19, 17:18
Russian experts create 3D model of Palmyra to be handed over to DamascusSociety & Culture October 19, 16:52
Moscow disappointed by Dutch side's 'biased' approach to MH17 crash investigationRussian Politics & Diplomacy October 19, 16:33
Meet Putin's presidential challenger - 'It Girl' turned 'anti-establishment' choiceRussian Politics & Diplomacy October 19, 16:13
New missiles for Russia’s Iskander-M system to help counter nuclear threat — senatorMilitary & Defense October 19, 16:09
Assad says defeating terrorists in Syria ruins West’s schemesWorld October 19, 15:52
Russia’s Natural Resources Ministry to increase environmental fee for plasticsBusiness & Economy October 19, 15:39
British BP considers participating in several new projects of RosneftBusiness & Economy October 19, 15:35
MANAGUA, October 22. /TASS/. The first Russian plant on vaccine production will open in Nicaragua on October 22, and production of vaccines may be launched right away as all lines are ready, Russian Healthcare Minister Veronika Skvortsova told reporters on Saturday.
"We came to solemnly open it. It may be launched right away - all lines are ready," Skvortsova said.
She also reminded that the decision to build a biomedical immune-biological facility was made in the framework of the Russian-Nicaraguan inter-governmental commission. The first stone was laid a year ago.
"Precisely a year ago, on 21 October 2015, we laid the first stone at the spot where biomedical biotechnological production of seasonal flu vaccines was to start," Veronika Skvortsova noted.
The capacity of the Russian plant to produce seasonal flu vaccines, due to be open on Sunday, is 30 million doses a year, Russia’s Healthcare Minister told reporters.
"The first capacity of this plant is 30 million doses a year, while Nicaragua’s demand is about one million doses," she said. "The remaining 29 million will be for the countries of Central and Latin America."
The output capacity of the Russian plant to produce seasonal flu vaccines may be increased by five times if required, she said.
In 2013, the Russia-Nicaragua intergovernmental commission agreed to build the bio medical immune biology facility. Presidents of the countries supported the decision. The plant will be opened on October 22.